ALLMedicine™ Lymphomatoid Papulosis Center
Research & Reviews 166 results
https://clinicaltrials.gov/ct2/show/NCT01352520
Dec 20th, 2022 - The Study Drug: Brentuximab vedotin is an antibody that is designed to find a certain protein (called CD30) on cancer cells and bind to it. It is designed to then enter the cell and release a molecule that may kill the cancer cells. Study Drug Adm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878077
Journal of Cutaneous Pathology; Bresler SC, Menge TD et. al.
Nov 29th, 2022 - COVID-19 infection and vaccination may be associated with a wide variety of cutaneous and immune manifestations. Here, we describe two patients who presented with monoclonal cutaneous T-cell infiltrates that showed cytologic and immunophenotypic f...
https://emedicine.medscape.com/article/1099078-treatment
Aug 24th, 2022 - Long-Term Monitoring Patients with a waxing and waning course of Mucha-Habermann disease require follow-up monitoring and additional treatment depending on the severity of the disease. The exact etiology of pityriasis lichenoides has yet to be elu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588576
The American Journal of Surgical Pathology; Feldman AL, Oishi N et. al.
Aug 9th, 2022 - Anaplastic large cell lymphoma (ALCL) can be classified genetically based on rearrangements (R) of the ALK , TP63 , and/or DUSP22 genes. ALK- R defines a specific entity, ALK-positive ALCL, while DUSP22- R and TP63- R define subgroups of ALK-negat...
https://doi.org/10.1016/j.clindermatol.2022.07.010
Clinics in Dermatology; Magro CM, Mo JH et. al.
Jul 31st, 2022 - Lymphomatoid papulosis (LYP), the most common primary cutaneous CD30-positive lymphoproliferative disorder, is heralded by multiple papular and nodular lesions at anatomically discontiguous cutaneous sites. The histologic patterns are protean. An ...
Clinicaltrials.gov 2 results
https://clinicaltrials.gov/ct2/show/NCT01352520
Dec 20th, 2022 - The Study Drug: Brentuximab vedotin is an antibody that is designed to find a certain protein (called CD30) on cancer cells and bind to it. It is designed to then enter the cell and release a molecule that may kill the cancer cells. Study Drug Adm...
https://clinicaltrials.gov/ct2/show/NCT03192202
Jul 16th, 2020 - This is an open label, Phase Ib/IIa study designed to evaluate the biologic activity of AFM13 in patients with relapsed or refractory CD30-positive lymphomas with cutaneous involvement. Primary cutaneous CD30-positive lymphoproliferative disorders...
News 24 results
https://www.mdedge.com/dermatology/article/255867/dermatopathology/rapidly-evolving-papulonodular-eruption-axilla
Saira Khan, PA-C, Thomas M. Brown Jr, DO et. al.
Jun 29th, 2022 - The Diagnosis: Lymphomatoid Papulosis At the time of the initial visit, a punch biopsy was performed on the posterior shoulder girdle. Histopathology revealed mild epidermal spongiosis and acanthosis with associated parakeratosis and a dermal lymp.
https://www.mdedge.com/dermatology/article/241494/dermatopathology/atrophic-lesions-pregnant-woman
Santana D. VanDyke, MD, Darren J. Guffey, MD et. al.
Jun 14th, 2021 - The Diagnosis: Degos Disease The pathophysiology of Degos disease (malignant atrophic papulosis) is unknown. 1 Histopathology demonstrates a wedge-shaped area of dermal necrosis with edema and mucin deposition extending from the papillary dermis to.
https://www.mdedge.com/dermatology/article/240498/nonmelanoma-skin-cancer/exuberant-lymphomatoid-papulosis-head-and-upper
Stephen Hemperly, DO, Nektarios Lountzis, MD et. al.
May 24th, 2021 - To the Editor: Lymphomatoid papulosis (LyP) is a chronic, recurring, self-healing, primary cutaneous lymphoproliferative disorder. This disease affects patients of all ages but most commonly presents in the fifth decade with a slight male predomin.
https://www.mdedge.com/dermatology/article/239893/dermatopathology/nodule-neck
Malan Kern, MD, Kelsey Parks, BS et. al.
May 11th, 2021 - The Diagnosis: Primary Cutaneous Anaplastic Large Cell Lymphoma Microscopic analysis showed a dense proliferation of mononuclear cells filling and expanding the dermis with focal epidermotropism (Figure 1). Immunohistochemistry demonstrated strong.
https://www.mdedge.com/dermatology/article/224269/nonmelanoma-skin-cancer/mycosis-fungoides-manifesting-morbilliform
Helena A. Jenkinson, MD, Phyu P. Aung, MD, PhD et. al.
Jun 22nd, 2020 - To the Editor: Mycosis fungoides (MF) is the most common type of primary cutaneous lymphoma, occurring in approximately 4 of 1 million individuals per year in the United States. 1 It classically occurs in patch, plaque, and tumor stages with lesion.